Centene Expects To Report Q2 GAAP EPS Of $2.16 And Adjusted EPS Of $2.42 (Est $1.96), Inclusive Of 2023 Risk Adjustment Outperformance
Centene Expects To Report Q2 GAAP EPS Of $2.16 And Adjusted EPS Of $2.42 (Est $1.96), Inclusive Of 2023 Risk Adjustment Outperformance
On July 22, 2024, the Centers for Medicare and Medicaid Services (CMS) published the final risk adjustment transfers for the 2023 benefit year, resulting in a final $0.0 billion receivable for Centene.
2024年7月22日，聯邦醫療保險和醫療補助服務中心(CMS)發佈了2023年風險調整轉移的最終結果，導致康西哥應收賬款爲$0億。
As a result of the publication of the benefit year 2023 reports, the Company is providing information regarding Centene's estimated net risk adjustment payable as of March 31, 2024, as well as summarizing the second quarter and expected full year 2024 financial impact of the 2023 risk adjustment results.
由於2023年報告的發佈，本公司提供有關康西哥截至2024年3月31日的估計淨風險調整應付款的信息，以及總結2023年風險調整結果對2024年第二季度和預期全年的財務影響。
As of March 31, 2024, Centene had recorded a $1.3 billion 2023 risk adjustment payable, net on the Consolidated Balance Sheet.
截至2024年3月31日，康西哥在合併資產負債表上記載了$13億2023年風險調整淨應付款。